The Asia-Pacific clinical trial management market is anticipated to grow at a CAGR of 13.55% during the forecast period, 2022-2030. The rising number of pharmaceutical and biopharmaceutical companies, the flourishing R&D sector, and the increasing awareness about clinical trial management products propel market growth.
ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET FORECAST 2022-2030
Asia-Pacific Clinical Trial Management Market by End-user (Pharmaceutical and Biopharmaceutical Companies, Clinical Research Organizations, Healthcare Providers) Market by Product Type (Enterprise-based CTM, Site-based CTM) Market by Deployment Model (Web-based Deployment, on-premise Deployment, Cloud-based Deployment) Market by Component (Software, Hardware, Services) by Geography
The Asia-Pacific clinical trial management market is anticipated to grow at a CAGR of 13.55% during the forecast period, 2022-2030. The rising number of pharmaceutical and biopharmaceutical companies, the flourishing R&D sector, and the increasing awareness about clinical trial management products propel market growth.
To learn more about this report, request a free sample copy
The Asia-Pacific clinical trial management market growth analysis includes the assessment of Vietnam, Thailand, Japan, China, South Korea, Australia & New Zealand, India, Indonesia, and Rest of Asia-Pacific. In China, the thriving pharmaceutical industry and increasing research in genomics majorly drive market growth. Also, organizations are collaborating to drive the adoption of clinical trial management products. It is the fifth-largest clinical trial market in the world and the largest in Asia. Phase I-III clinical trials have been on the rise in recent years. Further, the recent changes in regulations and policies have strengthened China’s clinical research fraternity. Moreover, the drug market is recording rapid growth. Such factors facilitate market growth in China.
In South Korea, the pharmaceutical industry growth is driven by exports, increased production of prescription and over-the-counter (OTC) drugs. Prescription drugs account for almost 83% of the production value. The government’s active support has supplemented the growth of clinical trials, with its aim to make the country a center of clinical trials. Furthermore, in Vietnam, one of the most dynamic emerging countries in East Asia, demographic changes and economic growth propel healthcare services demand. Hospitals, aided by government funds, are upgrading their facilities and opening new departments for specialty treatment. Such factors are projected to boost the market growth in these countries.
IBM Corporation provides integrated solutions, and operates through five segments, technology services & cloud platforms, global financing, systems, cognitive solutions, and global business services (GBS). It consistently invests in R&D to enhance its products and add new technologies. The company has its headquarters in New York, United States.
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- PARENT MARKET ANALYSIS – HEALTHCARE
- MARKET SCOPE
- KEY DRIVERS
- OUTSOURCING OF CLINICAL TRIALS
- GROWING NUMBER OF CLINICAL TRIALS
- AWARENESS REGARDING THE BENEFITS OF USING CTM SOFTWARE
- INCIDENCES OF CHRONIC DISEASES
- RESEARCH & DEVELOPMENT
- KEY RESTRAINTS
- SCARCITY OF SKILLED HEALTHCARE PROFESSIONALS
- COST OF IMPLEMENTATION
- SECURITY CONCERNS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON CLINICAL TRIAL MANAGEMENT MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- MARKET BY END-USER
- PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
- CLINICAL RESEARCH ORGANIZATIONS
- HEALTHCARE PROVIDERS
- MARKET BY PRODUCT TYPE
- ENTERPRISE-BASED CTM
- SITE-BASED CTM
- MARKET BY DEPLOYMENT MODEL
- WEB-BASED DEPLOYMENT
- ON-PREMISE DEPLOYMENT
- CLOUD-BASED DEPLOYMENT
- MARKET BY COMPONENT
- SOFTWARE
- HARDWARE
- SERVICES
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- CHINA
- JAPAN
- INDIA
- SOUTH KOREA
- INDONESIA
- THAILAND
- VIETNAM
- AUSTRALIA & NEW ZEALAND
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
- COMPANY PROFILES
- ADVARRA (FORTE RESEARCH SYSTEMS INC)
- ARISGLOBAL LLC
- BIOCLINICA INC
- BIO-OPTRONICS INC
- IBM CORPORATION
- MEDIDATA SOLUTIONS INC
- MEDNET SOLUTIONS INC
- ORACLE CORPORATION
- PAREXEL INTERNATIONAL CORPORATION
- VEEVA SYSTEMS INC
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – CLINICAL TRIAL MANAGEMENT
TABLE 2: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: KEY PLAYERS OPERATING IN ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET
TABLE 13: LIST OF MERGERS & ACQUISITIONS
TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 15: LIST OF PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
FIGURE 6: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY CLINICAL RESEARCH ORGANIZATIONS, 2022-2030 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY HEALTHCARE PROVIDERS, 2022-2030 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021
FIGURE 10: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY ENTERPRISE-BASED CTM, 2022-2030 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY SITE-BASED CTM, 2022-2030 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY DEPLOYMENT MODEL, IN 2021
FIGURE 13: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY WEB-BASED DEPLOYMENT, 2022-2030 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY ON-PREMISE DEPLOYMENT, 2022-2030 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY CLOUD-BASED DEPLOYMENT, 2022-2030 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2021
FIGURE 17: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY SOFTWARE, 2022-2030 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY HARDWARE, 2022-2030 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 21: CHINA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
FIGURE 22: JAPAN CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
FIGURE 23: INDIA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
FIGURE 24: SOUTH KOREA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
FIGURE 25: INDONESIA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
FIGURE 26: THAILAND CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
FIGURE 27: VIETNAM CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
FIGURE 28: AUSTRALIA & NEW ZEALAND CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
FIGURE 29: REST OF ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- CHINA
- JAPAN
- INDIA
- SOUTH KOREA
- INDONESIA
- THAILAND
- VIETNAM
- AUSTRALIA & NEW ZEALAND
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- MARKET BY END-USER
- PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
- CLINICAL RESEARCH ORGANIZATIONS
- HEALTHCARE PROVIDERS
- MARKET BY PRODUCT TYPE
- ENTERPRISE-BASED CTM
- SITE-BASED CTM
- MARKET BY DEPLOYMENT MODEL
- WEB-BASED DEPLOYMENT
- ON-PREMISE DEPLOYMENT
- CLOUD-BASED DEPLOYMENT
- MARKET BY COMPONENT
- SOFTWARE
- HARDWARE
- SERVICES
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.